Page last updated: 2024-09-04

levofloxacin and Blood Poisoning

levofloxacin has been researched along with Blood Poisoning in 42 studies

Research

Studies (42)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (4.76)	18.2507
2000's	13 (30.95)	29.6817
2010's	16 (38.10)	24.3611
2020's	11 (26.19)	2.80

Authors

Authors	Studies
Hoshino, K; Ishida, H; Ishida, Y; Kawato, H; Kurosaka, Y; Lee, VJ; Nakayama, K; Ohta, T; Ohtsuka, M; Otani, T; Renau, TE; Watkins, WJ; Yokomizo, Y; Yoshida, K	1
Achorn, C; Chen, CL; Clark, RB; Deng, Y; Fyfe, C; Grossman, TH; He, M; Hogan, PC; Hunt, DK; O'Brien, WJ; Plamondon, L; Rönn, M; Sutcliffe, JA; Xiao, XY; Zhu, Z	1
Almstead, NG; Arnold, MA; Baird, J; Branstrom, AA; Chen, G; Dumble, M; Gerasyuto, AI; Karp, GM; Narasimhan, J; Peddi, S; Prasad, JVN; Sheedy, J; Smith, S; Wang, J; Weetall, M; Woll, MG; Zhang, N; Zhang, X	1
Brackett, J; Campbell, JR; Davis, A; Foster, CE; Marquez, L; Sauer, HE; Stevens, AM	1
Ahmadi, F; Garg, AX; Kim, RB; Knoll, GA; Muanda, FT; Silverman, MS; Sontrop, JM; Sood, MM; Weir, MA; Yoo, E	1
Jia, P; Jia, X; Kang, M; Li, R; Li, X; Liu, X; Xu, Y; Yang, Q; Yu, W; Zhu, Y	1
Akazawa, N; Itoh, N; Kuwahara, T; Yanaidani, T	1
Chen, J; Liu, W; Zhao, F	1
Chen, S; Kou, Z; Li, R; Liu, Y; Wang, Q; Wang, X	1
Chang, FY; Lai, JJ; Lin, JC; Siu, LK; Wang, CH; Wu, RX; Yu, CM	1
Acker, KP	1
Bientinesi, R; Murri, R; Sacco, E	1
Kanderi, T; Komanduri, S; Mansoora, Q; Shah, K; Shrimanker, I; Yumen, A	1
Bauer, M; Cheng, S; Gallardo, L; Hellman, J; Jackson, N; Konovalova, A; McNamara, C; Michel, LV; Pichichero, ME; Pierce, J; Snyder, E; Zavorin, M	1
Mueller, BA; Shaw, AR	1
Bauer, M; Kölsch, U; Krüger, R; Meisel, C; Unterwalder, N; von Bernuth, H; Wahn, V	1
Doi, SAR; Harris, PN; Naber, K; Roberts, MJ; Scott, S; Wagenlehner, FME	1
Ansart, S; Gazeau, P; Quaesaet, L; Rezig, S; Tande, D; Williams, T	1
Lenart, KS; Ostorhazi, E; Szabo, BG; Tirczka, T	1
Bilker, W; Bink, K; Fitzpatrick, R; Gilmar, C; Gorman, T; Han, JH; Kraus, K; Kucharczuk, C; Landsburg, D; Mangan, P; Moore, A; Pegues, D; Stadtmauer, EA; Ziegler, M	1
Bernard, S; Lee, K; Pakyz, A; Stevens, M; Vaughan, D	1
Andrés, M; Aquilino, A; Galiana, AJ; Gutiérrez, F; López, P; Masiá, M; Tovar, J	1
Bolduc, DL; Elliott, TB; Fatanmi, OO; Kiang, JG; Ledney, GD; Newman, VL; Romaine, PL; Singh, VK; Wise, SY	1
Geerlings, SE; Holleman, F; Schneeberger, C	1
Deis, AS; Simpson, SQ; Whiles, BB	1
Gea-Banacloche, JC; Green, O; Murray, P	1
Calista, F; Fadda, G; Fiori, B; Mignogna, S; Romano, L; Sali, M; Spanu, T; Zappacosta, B	1
Akduman, B; Akduman, D; Ayoğlu, F; Erol, B; Mungan, NA; Tokgöz, H; Türker, T	1
Lemus-Peñaloza, J; Parra-Riffo, H	1
Dehghanyar, P; Georgopoulos, A; Heinz, G; Joukhadar, C; Mayer, BX; Müller, M; Neckel, U; Schenk, BS; Zeitlinger, MA	1
Al-Khadimi, Z; Chow, WA; Doroshow, JH; Frankel, P; Lawrence, J; Leong, L; Lim, D; Longmate, J; Margolin, K; Morgan, RJ; Raschko, J; Shibata, S; Somlo, G; Synold, TW; Tetef, ML; Twardowski, P; Yen, Y	1
Alba, L; Antinori, A; Boumis, E; Festa, A; Marconi, P; Paglia, MG; Pucillo, LP; Visca, P	1
Aguilar, L; Alkorta, M; Giménez, MJ; Pérez-Trallero, E; Vicente, D	1
Brezinka, C; Gritsch, W; Hotzel, H; Ploner, F; Tauber, R; Walder, G; Würzner, R	1
Järvinen, A; Kauma, H; Koivula, I; Kotilainen, P; Lumio, J; Nikoskelainen, J; Rintala, E; Ruotsalainen, E; Vaara, M; Valtonen, V	1
Cho, D; Corcoran, E; Dudley, MN; Griffith, DC; Lee, A; Lofland, D; Lomovskaya, O	1
Barth, J; Hochhaus, G; Jäger, D; Kaufmann, S; Tayab, ZR	1
Czock, D; de Groot, K; Fliser, D; Hafer, C; Haller, H; Hüsig-Linde, C; Keller, F; Kielstein, JT; Kuse, E; Langhoff, A; Schöpke, T; Swoboda, S	1
Fujisawa, M; Miura, T; Nakano, Y; Shigemura, K; Takenaka, A; Tanaka, K	1
Geweniger, KH; Isert, D; Iyer, P; Klesel, N; Koletzki, P; Limbert, M; Markus, A; Riess, G; Schramm, H	1
Geddes, A; Härkönen, M; Jacobs, F; Nowotny, I; Schonwald, S; Thaler, M	1
Eda, T; Hosaka, M; Hoshino, K; Inoue, M; Kaieda, S; Kitasato, H; Kuga, A; Okamoto, R; Sato, Y; Seto, I	1

Reviews

6 review(s) available for levofloxacin and Blood Poisoning

Article	Year
Efficacy and safety of levofloxacin as a treatment for complicated urinary tract infections and pyelonephritis. Expert opinion on pharmacotherapy, 2020, Volume: 21, Issue:6 Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Female; Humans; Infection Control; Levofloxacin; Pyelonephritis; Sepsis; Urinary Tract Infections	2020
Antibiotic Dosing in Continuous Renal Replacement Therapy. Advances in chronic kidney disease, 2017, Volume: 24, Issue:4 Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Computer Simulation; Critical Illness; Humans; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Monte Carlo Method; Penicillanic Acid; Piperacillin; Renal Replacement Therapy; Sepsis; Tazobactam; Thienamycins	2017
Comparison of fosfomycin against fluoroquinolones for transrectal prostate biopsy prophylaxis: an individual patient-data meta-analysis. World journal of urology, 2018, Volume: 36, Issue:3 Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Biopsy, Large-Core Needle; Ciprofloxacin; Fluoroquinolones; Fosfomycin; Humans; Image-Guided Biopsy; Levofloxacin; Male; Middle Aged; Prostate; Sepsis; Ultrasonography; Urinary Tract Infections	2018
Febrile urinary tract infections: pyelonephritis and urosepsis. Current opinion in infectious diseases, 2016, Volume: 29, Issue:1 Topics: Anti-Infective Agents, Urinary; Cephalosporins; Diabetes Complications; Fever; Humans; Immunocompromised Host; Levofloxacin; Penicillanic Acid; Pyelonephritis; Randomized Controlled Trials as Topic; Risk Factors; Sepsis; Tazobactam; Treatment Outcome; Urinary Tract Infections	2016
Severe levofloxacin-induced hypoglycaemia: a case report and literature review. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2012, Jul-17, Volume: 32, Issue:4 Topics: Aged; Anti-Bacterial Agents; Catheter-Related Infections; Drug Therapy, Combination; Enterococcus; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Hypoglycemia; Immunocompromised Host; Kidney Failure, Chronic; Levofloxacin; Male; Ofloxacin; Renal Dialysis; Sepsis; Stenotrophomonas maltophilia; Trimethoprim, Sulfamethoxazole Drug Combination	2012
Levofloxacin resistant Escherichia coli sepsis following an ultrasound-guided transrectal prostate biopsy: report of four cases and review of the literature. International journal of urology : official journal of the Japanese Urological Association, 2008, Volume: 15, Issue:5 Topics: Aged; Anti-Bacterial Agents; Biopsy; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prostate; Rectum; Sepsis; Ultrasonography	2008

Trials

4 trial(s) available for levofloxacin and Blood Poisoning

Article	Year
Feasibility and pharmacokinetic study of infusional dexrazoxane and dose-intensive doxorubicin administered concurrently over 96 h for the treatment of advanced malignancies. Cancer chemotherapy and pharmacology, 2004, Volume: 54, Issue:3 Topics: Adult; Antibiotics, Antineoplastic; Cardiovascular Agents; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Granulocyte Colony-Stimulating Factor; Heart Failure; Humans; Infusions, Intravenous; Levofloxacin; Male; Middle Aged; Neoplasms; Neutropenia; Ofloxacin; Razoxane; Sarcoma; Sepsis; Treatment Outcome	2004
Levofloxacin does not decrease mortality in Staphylococcus aureus bacteraemia when added to the standard treatment: a prospective and randomized clinical trial of 381 patients. Journal of internal medicine, 2006, Volume: 259, Issue:2 Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Chi-Square Distribution; Drug Therapy, Combination; Female; Finland; Humans; Levofloxacin; Male; Middle Aged; Odds Ratio; Ofloxacin; Penicillins; Prospective Studies; Rifampin; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Treatment Failure	2006
Do intensive care patients need an individualized dosing regimen for levofloxacin? International journal of clinical pharmacology and therapeutics, 2006, Volume: 44, Issue:6 Topics: Anti-Bacterial Agents; Critical Illness; Female; Humans; Intensive Care Units; Levofloxacin; Male; Middle Aged; Models, Biological; Ofloxacin; Pancreatitis; Pneumonia, Bacterial; Sepsis	2006
Levofloxacin in the empirical treatment of patients with suspected bacteraemia/sepsis: comparison with imipenem/cilastatin in an open, randomized trial. The Journal of antimicrobial chemotherapy, 1999, Volume: 44, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacteremia; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Levofloxacin; Middle Aged; Ofloxacin; Protease Inhibitors; Sepsis; Thienamycins	1999

Other Studies

32 other study(ies) available for levofloxacin and Blood Poisoning

Article	Year
MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 2: achieving activity in vivo through the use of alternative scaffolds. Bioorganic & medicinal chemistry letters, 2003, Dec-01, Volume: 13, Issue:23 Topics: Animals; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Biological Transport, Active; Carrier Proteins; Drug Resistance, Microbial; Fluoroquinolones; Gene Expression Regulation, Bacterial; Lactams; Levofloxacin; Membrane Transport Proteins; Mice; Microbial Sensitivity Tests; Neutropenia; Ofloxacin; Protein Binding; Pseudomonas aeruginosa; Rats; Sepsis; Serum Albumin; Structure-Activity Relationship	2003
Fluorocyclines. 2. Optimization of the C-9 side-chain for antibacterial activity and oral efficacy. Journal of medicinal chemistry, 2012, Jan-26, Volume: 55, Issue:2 Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Biological Availability; Cyclophosphamide; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Lung; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Neutropenia; Rats; Rats, Sprague-Dawley; Respiratory Tract Infections; Ribosomes; Sepsis; Stereoisomerism; Structure-Activity Relationship; Tetracycline Resistance; Tetracyclines	2012
Discovery and Optimization of Indolyl-Containing 4-Hydroxy-2-Pyridone Type II DNA Topoisomerase Inhibitors Active against Multidrug Resistant Gram-negative Bacteria. Journal of medicinal chemistry, 2018, 05-24, Volume: 61, Issue:10 Topics: Animals; Anti-Bacterial Agents; DNA Topoisomerases, Type II; Drug Discovery; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Mice; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Protein Conformation; Pyridines; Sepsis; Structure-Activity Relationship; Topoisomerase II Inhibitors	2018
Levofloxacin prophylaxis for pediatric leukemia patients: Longitudinal follow-up for impact on health care-associated infections. Pediatric blood & cancer, 2022, Volume: 69, Issue:7 Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Child; Clostridioides difficile; Cross Infection; Delivery of Health Care; Diarrhea; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Levofloxacin; Retrospective Studies; Sepsis	2022
Association of Higher-Dose Fluoroquinolone Therapy With Serious Adverse Events in Older Adults With Advanced Chronic Kidney Disease. JAMA network open, 2022, 08-01, Volume: 5, Issue:8 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Cohort Studies; Death, Sudden, Cardiac; Female; Fluoroquinolones; Humans; Hypoglycemia; Levofloxacin; Norfloxacin; Ontario; Renal Dialysis; Renal Insufficiency, Chronic; Retinal Detachment; Sepsis	2022
Emergence of a Novel NDM-5-Producing Sequence Type 4523 Klebsiella pneumoniae Strain Causing Bloodstream Infection in China. Microbiology spectrum, 2022, 10-26, Volume: 10, Issue:5 Topics: Aged; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cephalosporins; Colistin; Female; Formaldehyde; Humans; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Plasmids; Sepsis	2022
Clinical and microbiological features of intratumor abscess with bloodstream infection caused by Plesiomonas shigelloides, Citrobacter freundii, Streptococcus mitis/oralis, Clostridium perfringens, and Candida albicans in a patient with cholangiocarcinoma Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2022, Volume: 28, Issue:12 Topics: Abscess; Aged; Antifungal Agents; Bacteremia; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Candida albicans; Cholangiocarcinoma; Citrobacter freundii; Clostridium perfringens; Humans; Levofloxacin; Male; Piperacillin; Plesiomonas; RNA, Ribosomal, 16S; Sepsis; Soil; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Streptococcus mitis; Streptococcus oralis; Tazobactam	2022
Analysis of drug resistance genes of integrons in clinical isolates of Escherichia coli from elderly bloodstream infections. Cellular and molecular biology (Noisy-le-Grand, France), 2022, Jun-30, Volume: 68, Issue:6 Topics: Aged; Amikacin; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cefoxitin; Clavulanic Acid; Drug Resistance; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Integrons; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Minocycline; Sepsis; Ticarcillin; Trimethoprim, Sulfamethoxazole Drug Combination	2022
Case report: One human Streptococcus suis occurred in Shandong Province, China. Medicine, 2022, Dec-23, Volume: 101, Issue:51 Topics: Aged; Animals; China; Humans; Levofloxacin; Male; Sepsis; Streptococcal Infections; Streptococcus suis; Swine; Zoonoses	2022
Appropriate antibiotic therapy is a predictor of outcome in patients with Stenotrophomonas maltophilia blood stream infection in the intensive care unit. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2023, Volume: 56, Issue:3 Topics: Anti-Bacterial Agents; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Levofloxacin; Retrospective Studies; Sepsis; Stenotrophomonas maltophilia; Trimethoprim, Sulfamethoxazole Drug Combination	2023
Editorial Commentary: Impact of Fluoroquinolone Prophylaxis on Viridans Group Streptococci Bloodstream Infections in Immunocompromised Children. Journal of the Pediatric Infectious Diseases Society, 2023, 07-31, Volume: 12, Issue:7 Topics: Anti-Bacterial Agents; Child; Fluoroquinolones; Humans; Levofloxacin; Sepsis; Viridans Streptococci	2023
Stenotrophomonas maltophilia: An Emerging Pathogen of the Respiratory Tract. The American journal of case reports, 2020, May-25, Volume: 21 Topics: Aged; Anti-Bacterial Agents; Fatal Outcome; Female; Gram-Negative Bacterial Infections; Heart Arrest; Humans; Levofloxacin; Opportunistic Infections; Pneumonia; Sepsis; Stenotrophomonas maltophilia; Trimethoprim, Sulfamethoxazole Drug Combination	2020
Ampicillin triggers the release of Pal in toxic vesicles from Escherichia coli. International journal of antimicrobial agents, 2020, Volume: 56, Issue:6 Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Escherichia coli; Escherichia coli Proteins; Gentamicins; Humans; Levofloxacin; Lipoproteins; Microbial Sensitivity Tests; Peptidoglycan; Sepsis	2020
Antibiotic Prophylaxis, Immunoglobulin Substitution and Supportive Measures Prevent Infections in MECP2 Duplication Syndrome. The Pediatric infectious disease journal, 2018, Volume: 37, Issue:5 Topics: Administration, Intravenous; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Humans; IgA Deficiency; IgG Deficiency; Immunoglobulin M; Immunoglobulins; Levofloxacin; Male; Mental Retardation, X-Linked; Pneumonia; Sepsis; Young Adult	2018
Erysipelothrix rhusiopathiae knee prosthesis infection. Medecine et maladies infectieuses, 2018, Volume: 48, Issue:5 Topics: Aged, 80 and over; Amoxicillin; Arthroplasty, Replacement, Knee; Ceftriaxone; Chemical and Drug Induced Liver Injury; Drug Substitution; Erysipelothrix; Erysipelothrix Infections; Humans; Knee Prosthesis; Levofloxacin; Male; Prosthesis-Related Infections; Recurrence; Reoperation; Sepsis	2018
Clinical and microbiological characteristics of adult invasive Haemophilus influenzae infections: results of a 14-year single-center experience from Hungary. Infection, 2018, Volume: 46, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Drug Resistance, Bacterial; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Hungary; Incidence; Levofloxacin; Male; Middle Aged; Retrospective Studies; Sepsis	2018
Fluoroquinolone Prophylaxis Is Highly Effective for the Prevention of Central Line-Associated Bloodstream Infections in Autologous Stem Cell Transplant Patients. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2019, Volume: 25, Issue:5 Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Clostridium Infections; Febrile Neutropenia; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infection Control; Infections; Levofloxacin; Male; Middle Aged; Sepsis; Transplantation, Autologous	2019
Adequacy of empiric gram-negative coverage for septic patients at an academic medical center. American journal of infection control, 2019, Volume: 47, Issue:10 Topics: Academic Medical Centers; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cephalosporins; Female; Gram-Negative Bacteria; Humans; Levofloxacin; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis; Shock, Septic; Virginia; Young Adult	2019
First human systemic infection caused by Spiroplasma. Journal of clinical microbiology, 2015, Volume: 53, Issue:2 Topics: Agammaglobulinemia; Aged; Anti-Bacterial Agents; Blood; DNA, Bacterial; Doxycycline; Female; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Microbiological Techniques; Molecular Sequence Data; Sepsis; Sequence Analysis, DNA; Spiroplasma; Treatment Outcome	2015
Combined immunomodulator and antimicrobial therapy eliminates polymicrobial sepsis and modulates cytokine production in combined injured mice. International journal of radiation biology, 2015, Volume: 91, Issue:9 Topics: Amoxicillin; Animals; Anti-Infective Agents; Bacterial Infections; Chemokines; Cord Factors; Cytokines; Disease Models, Animal; Drug Therapy, Combination; Female; Gamma Rays; Growth Substances; Immunologic Factors; Levofloxacin; Lipid A; Mice; Radiation Injuries, Experimental; Sepsis; Skin; Wound Infection	2015
Increased Time to Initial Antimicrobial Administration Is Associated With Progression to Septic Shock in Severe Sepsis Patients. Critical care medicine, 2017, Volume: 45, Issue:4 Topics: Adult; Aged; Anti-Bacterial Agents; Ceftriaxone; Comorbidity; Disease Progression; Female; Hospital Mortality; Humans; Length of Stay; Levofloxacin; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis; Sex Factors; Shock, Septic; Time Factors; Time-to-Treatment; Vasoconstrictor Agents	2017
Sepsis caused by Elizabethkingia miricola successfully treated with tigecycline and levofloxacin. Diagnostic microbiology and infectious disease, 2008, Volume: 62, Issue:4 Topics: Anti-Bacterial Agents; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Lymphoma, Mantle-Cell; Male; Middle Aged; Minocycline; Ofloxacin; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Sepsis; Stem Cell Transplantation; Tigecycline	2008
Tsukamurella tyrosinosolvens and Rhizobium radiobacter sepsis presenting with septic pulmonary emboli. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2011, Volume: 17, Issue:7 Topics: Actinomycetales; Actinomycetales Infections; Aged; Agrobacterium tumefaciens; Anti-Bacterial Agents; Catheter-Related Infections; Catheterization, Central Venous; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Ofloxacin; Pulmonary Embolism; Radiography, Thoracic; Sepsis; Tomography, X-Ray Computed	2011
Long-term fluoroquinolone use before the prostate biopsy may increase the risk of sepsis caused by resistant microorganisms. Urology, 2011, Volume: 78, Issue:2 Topics: Aged; Anti-Infective Agents; Antibiotic Prophylaxis; Biopsy, Needle; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Retrospective Studies; Risk Factors; Sepsis; Time Factors	2011
Relevance of soft-tissue penetration by levofloxacin for target site bacterial killing in patients with sepsis. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:11 Topics: Aged; Anti-Infective Agents; Area Under Curve; Blood Proteins; Drug Delivery Systems; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Protein Binding; Pseudomonas Infections; Sepsis; Staphylococcal Infections	2003
Short Communication: Yersinia pseudotuberculosis septicemia in an HIV-infected patient failed HAART. AIDS research and human retroviruses, 2004, Volume: 20, Issue:7 Topics: Adult; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Ceftriaxone; Drug Therapy, Combination; Female; Humans; Levofloxacin; Ofloxacin; Sepsis; Treatment Failure; Yersinia pseudotuberculosis; Yersinia pseudotuberculosis Infections	2004
In vivo activity of gemifloxacin, moxifloxacin and levofloxacin against pneumococci with gyrA and parC point mutations in a sepsis mouse model measured with the all or nothing mortality end-point. International journal of antimicrobial agents, 2005, Volume: 25, Issue:2 Topics: Animals; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Disease Models, Animal; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Female; Fluoroquinolones; Gemifloxacin; Levofloxacin; Mice; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Pneumococcal Infections; Point Mutation; Quinolines; Sepsis; Streptococcus pneumoniae; Treatment Outcome	2005
An unusual cause of sepsis during pregnancy: recognizing infection with chlamydophila abortus. Obstetrics and gynecology, 2005, Volume: 106, Issue:5 Pt 2 Topics: Abortion, Spontaneous; Adult; Animals; Chlamydophila psittaci; Female; Goat Diseases; Goats; Humans; Levofloxacin; Macrolides; Ofloxacin; Pregnancy; Pregnancy Complications, Infectious; Psittacosis; Risk Factors; Sepsis; Zoonoses	2005
Pharmacodynamics of levofloxacin against Pseudomonas aeruginosa with reduced susceptibility due to different efflux pumps: do elevated MICs always predict reduced in vivo efficacy? Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:5 Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Bacterial Outer Membrane Proteins; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Gene Deletion; Genes, Bacterial; Levofloxacin; Male; Membrane Proteins; Membrane Transport Proteins; Mice; Microbial Sensitivity Tests; Neutropenia; Ofloxacin; Pseudomonas aeruginosa; Sepsis	2006
Pharmacokinetics of moxifloxacin and levofloxacin in intensive care unit patients who have acute renal failure and undergo extended daily dialysis. Clinical journal of the American Society of Nephrology : CJASN, 2006, Volume: 1, Issue:6 Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Anuria; Aza Compounds; Critical Care; Critical Illness; Female; Fluoroquinolones; Humans; Intensive Care Units; Levofloxacin; Male; Metabolic Clearance Rate; Middle Aged; Moxifloxacin; Multiple Organ Failure; Ofloxacin; Quinolines; Renal Dialysis; Sepsis	2006
Chemotherapeutic activity of levofloxacin (HR 355, DR-3355) against systemic and localized infections in laboratory animals. The Journal of antimicrobial chemotherapy, 1995, Volume: 35, Issue:6 Topics: Abscess; Animals; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Female; Granuloma; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Male; Mice; Mice, Inbred C3H; Microbial Sensitivity Tests; Ofloxacin; Pneumonia, Pneumococcal; Pyelonephritis; Rats; Rats, Wistar; Sepsis; Stereoisomerism; Streptococcus pneumoniae	1995
[In vitro antibacterial activity of prulifloxacin, a new oral quinolone, and comparative susceptibility rate at clinical breakpoint MIC]. The Japanese journal of antibiotics, 2000, Volume: 53, Issue:9 Topics: Anti-Infective Agents; Bacteria; Dioxolanes; Drug Resistance, Microbial; Fluoroquinolones; Humans; Levofloxacin; Ofloxacin; Piperazines; Quinolones; Respiratory Tract Infections; Sepsis	2000